Anxiety disorders, comorbid substance abuse, and benzodiazepine discontinuation: implications for treatment.
Barlow
D H
DH
Department of Psychology, State University of New York at Albany 12222, USA.
D000437:Alcoholism / Q000453:epidemiology; D001008:Anxiety Disorders / Q000453:epidemiology* / Q000628:therapy*; D001569:Benzodiazepines / Q000627:therapeutic use; D015897:Comorbidity; D006801:Humans; D019966:Substance-Related Disorders / Q000453:epidemiology* / Q000628:therapy*; D014481:United States / Q000453:epidemiology
D001569:Benzodiazepines